ARTICLE | Company News

Management tracks: Voyager, Chrono

February 2, 2018 12:41 AM UTC

Voyager Therapeutics Inc. (NASDAQ:VYGR) said CEO and President Steven Paul will transition to executive science advisor. The gene therapy company is seeking a replacement.

Drug delivery company Chrono Therapeutics Inc. (Hayward, Calif.) said CEO and Chairman Alan Levy is retiring. He is succeeded by David Happel as CEO and director James Young as chairman. Happel was EVP of commercial development and strategy at Horizon Pharma plc (NASDAQ:HZNP)...